10mg retatrutide reconstitution Reta vial GLP-3 Retatrutide · Disguised Alpha

Past medication responses tell us everything

Noom Microdose GLP-1 Protocol Noom Meds GLP-1 microdosing program uses compounded semaglutide starting at 0.1-0.2mg combined with behavioral coaching

GLP-1 agonists are being used in combination with basal insulin (Dungan & DeSantis, 2016), although this is not an FDA-approved indication (see rxlist.com) they should not be used as a substitute for basal insulin, as this has been found to result in a decline in glycemic control)(Dungan & DeSantis, 2016) Clinical trials indicate it can reduce HbA1c by ~0.8% Undergoes renal clearance, with dosage reduction needed if creatinine clearance falls to 1.5

This is particularly beneficial for our patients managing type 2 diabetes or prediabetes, as it supports both weight loss and glycemic control